biker1000
09 Jun 2015
Re: CRX not showing on III It does not appear to be showing on mine either.Can anyone assist?
Carefully Does It
06 Jun 2015
Re: Share Mag The future is bright and US problems are in the price. This can easily double in 18 months. #1 in their segment and tooled up on both sides of the pond to respond to multiple market segments and geographies.
up protherics
06 Jun 2015
Share Mag Good write up in this weeks share magazine.. N1 Singer predict growth rate of 260% for current financial year.. Personally I cant work out how they have got to that figure as they also say turnover will be 13.4 million for the year.One negative is that sales in the U.S are still flat..
vandeheide
03 Jun 2015
CRX not showing on III Anyone know why CRX is not showing on III?
up protherics
02 Jun 2015
Cipa initiative Has anyone an idea as to how much revenue Cyprotex could receive if the initiative replaces existing tests..If the previous tests become obsolete and replaced by tests Cyprotex is offering then surely this could be transformational for the company.
Carefully Does It
01 Jun 2015
Re: Market Expectations it's all good.revisions upwards, abot time.new treatments, chemicals, potions, they all need testing.onward and upward.
up protherics
01 Jun 2015
Market Expectations And what exactly was the market expectation.. ??????Whats the betting that there will be some negative news to follow
Altolusso
20 Apr 2015
Re: Results High operational gearing should have kicked in many years ago, but never quite seems to happen...
up protherics
16 Apr 2015
Convertable charge I am completely baffled..Why has the adjustment to the balance sheet only equated to a positive adjustment of £ 260,000 when the average share price for 30 days prior to year end results was below the conversion price.We are looking at a 20 pence price difference between this and the previous year end results. How come we are not reflecting a positive adjustment of at least one million back to the balance sheet. ???????
up protherics
16 Apr 2015
Re: Results Once again here is hoping your right.. More restrictions on animal testing would be nice together with further exceptence on alternative testing.What I would look to see is a trading update on the current year before the interims are due as we are now four months into the year.
Carefully Does It
15 Apr 2015
Re: Results The forward look is very positive in my view.The major costs have happened and both US and UK side are some of the very best equipped.High operational gearing is the clue. Give it 6 months to see the trend change.They now have the best set-up available. A 'go to' company.
up protherics
15 Apr 2015
Results Any views anyone.Personally I am not happy.. To me it looks like they are being left behind and the loan which was expensive to start with is proving even more expensive nowOne consolation is that what ever happens the company will be sold for at least 60 pence. So a buying opportunity when this drops again. For me a selling opportunity if it holds at current levels.Only my opinion so DYOR shouldn't be hard
up protherics
03 Apr 2015
Re: News All sounds good.. Just need to see some positive sales results on the back of it.. Also have you any idea as to how much has been invested in the new lab.
Carefully Does It
31 Mar 2015
Re: News It's fully open for volume business. Growth will kick in.Now is the time to be more confident for the future.
up protherics
31 Mar 2015
News All sounds good, but where are the results.. More importantly where are the sales figures.INMO until we actually see the investments paying off its not worth anything .Unless you are a pharma wanting to buy a fully equipped research company
